Evidence map›Paper›PMID 33216032›Full record

ArticleJournal of Alzheimer's disease : JAD2021

Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging.

Janina Krell-Roesch, Jeremy A Syrjanen, Jelena Bezold, Sandra Trautwein, Bettina Barisch-Fritz, Klaus Boes, Alexander Woll, Erica Forzani, Walter K Kremers, Mary M Machulda and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Physical activity and the outcome of cognitive trajectory: a machine learning approach.European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2025
    Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Janina Krell-RoeschDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Jeremy A SyrjanenDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Jelena BezoldInstitute of Sports and Sports Science, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Sandra TrautweinInstitute of Sports and Sports Science, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Bettina Barisch-FritzInstitute of Sports and Sports Science, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Klaus BoesInstitute of Sports and Sports Science, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Alexander WollInstitute of Sports and Sports Science, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Erica ForzaniBiodesign Institute, Arizona State University, Tempe, AZ, USA.
Walter K KremersDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Mary M MachuldaDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Michelle M MielkeDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
David S KnopmanDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Ronald C PetersenDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Maria VassilakiDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Yonas E GedaBiodesign Institute, Arizona State University, Tempe, AZ, USA.
Karlsruhe Institute of Technology · DEMayo Clinic in Arizona · USMayo Clinic in Florida · USArizona State University · USBarrow Neurological Institute · USMayo Clinic · US

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PETERSEN, RONALD C · 1999 to 2018
$36.9M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2019 to 2026
$33.5M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR33AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2020 to 2022
$2.4M
Pathways linking neuropsychiatric symptoms with Alzheimer's disease neuroimaging biomarkers and the outcome of incident Mild Cognitive Impairment/ DementiaR01AG057708 · NIA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI GEDA, YONAS E · 2018 to 2022
$1.7M
Psychiatric Characterization/Mild Cognitive ImpairmentK01MH068351 · NIMH · MAYO CLINIC ROCHESTER · PI GEDA, YONAS E · 2004 to 2008
$890k
NIA NIH HHS P30 AG062677NIA NIH HHS P50 AG016574NIA NIH HHS R01 AG034676NIA NIH HHS R01 AG057708NIA NIH HHS R33 AG058738NIA NIH HHS U01 AG006786NIMH NIH HHS K01 MH068351
6 · The paper itself

Abstract

backgroundLittle is known about the association between physical activity (PA) and cognitive trajectories in older adults.

objectiveTo examine the association between PA and change in memory, language, attention, visuospatial skills, and global cognition, and a potential impact of sex or Apolipoprotein E (APOE) ɛ4 status.

methodsLongitudinal study derived from the population-based Mayo Clinic Study of Aging, including 2,060 cognitively unimpaired males and females aged ≥70 years. Engagement in midlife (ages 50-65) and late-life (last year) PA was assessed using a questionnaire. Neuropsychological testing was done every 15 months (mean follow-up 5.8 years). We ran linear mixed-effect models to examine whether mid- or late-life PA at three intensities (mild, moderate, vigorous) was associated with cognitive z-scores.

resultsLight intensity midlife PA was associated with less decline in memory function compared to the no-PA reference group (time x light PA; estimate [standard error] 0.047 [0.016], p = 0.004). Vigorous late-life PA was associated with less decline in language (0.033 [0.015], p = 0.030), attention (0.032 [0.017], p = 0.050), and global cognition (0.039 [0.016], p = 0.012). Females who were physically inactive in midlife experienced more pronounced cognitive decline than females physically active in midlife and males regardless of PA (p-values for time interaction terms with midlife PA levels and sex were all p < 0.05 for global cognition). APOE ɛ4 carriership did not moderate the association between PA and cognition.

conclusionEngaging in PA, particularly of vigorous intensity in late-life, was associated with less pronounced decline in global and domain-specific cognition. This association may differ by sex.

Indexed as

AgedAged, 80 and overApolipoprotein E4AttentionCognitionCognitive AgingCognitive DysfunctionExerciseFemaleHumansLanguageLongitudinal StudiesMaleMemoryPsychomotor PerformanceSex FactorsApolipoprotein E4Cognitive trajectoriescommunity-dwelling personslate-lifemidlifephysical activity

Identifiers

PMID33216032
PMCPMC7839815
OpenAlexW3099330048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.